Zalypsis, formerly known as PM-10450, is transcription factor inhibitor potentially for the treatment of lymphoma, and cervical carcinoma. References: Moneo V, Serelde BG, Blanco-Aparicio C, Diaz-Uriarte R, Avilés P, Santamaría G, Tercero JC, Cuevas C, Carnero A. Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis. BMC Cancer. 2014 Apr 23;14:281. doi: 10.1186/1471-2407-14-281. PubMed PMID: 24758355; PubMed Central PMCID: PMC4023704.

纯度：≥98%

CAS：308359-57-1